ABL Bio Inc. (Kosdaq: 298380) is a South Korean biotechnology company dedicated to the development of bispecific antibody therapeutics to improve and save people's lives.
With our BsAb platforms ‘Grabody-T,’ ‘Grabody-I’ and ‘Grabody-B,’ we have built a robust pipeline of multiple clinical and pre-clinical stage drug candidates. In the oncology area, we have developed Grabody-T, a modular 4-1BB engaging platform that has demonstrated excellent efficacy and safety. We also created a next-generation antibody drug conjugate program to treat various cancers.
In the neurodegenerative disorder space, we have developed Grabody-B platform, which is designed to maximize blood-brain barrier (BBB) penetration. Grabody-B is applicable to various CNS targets across a plethora of neurological disorders, potentially providing a breakthrough to address the high unmet medical needs in neurodegeneration.
We continue to actively expand and advance our pipeline through global strategic partnerships. For more information, please visit http://ablbio.com
Company Details
- Employees
- 59
- Founded
- -
- Address
- 16 Daewangpangyo-Ro 712 Beon-Gil, Bundang-Gu, Seongnam-Si,gyeonggi-Do 13488,korea, Republic Of
- Phone
- (82)10-9191-5219
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- ablbio.com
- Keywords
- Biotechnology, Bispecific Antibody, BBB Penetration, Immuno-Oncology, ADC, 4-1BB, neurodegeneration, antibody.
- HQ
- Seongnam-si, Gyeonggi-do
Abl Bio Inc. Questions
Abl Bio Inc.'s helpline number is (82)10-9191-5219
Abl Bio Inc.'s website is ablbio.com
Abl Bio Inc.'s LinkedIn profile is https://kr.linkedin.com/company/ablbio
Abl Bio Inc. has
59 employees.
View email and phone details for 59
employees at Abl Bio Inc..
Abl Bio Inc.'s industry is
Biotechnology Research
Abl Bio Inc.'s top competitors are
Vesalius Therapeutics,
Alteogen,
Muna Therapeutics,
I-Mab Biopharma,
Gsk,
Yuhan Corporation,
Tempest Therapeutics,
Rhythm Pharmaceuticals Inc.,
Sangamo Therapeutics, Inc.,
Abl.
Abl Bio Inc.'s categories are Biotechnology Research
Abl Bio Inc.'s founding year is 2016
